- Credit Amounts:
- CME: 0.75
- Other: 0.75
- CPHCE: 1.00
- Cost: Free
- Release: Sep 8, 2019
- Expires: Sep 7, 2022
- Estimated Time to Complete:
45 Minutes - System Requirements:
-
Average User Rating:
(6 Ratings)
Faculty

Associate Professor, Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic, Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts
Associate Professor of Medicine
Director, Viral Hepatitis Clinic (Infectious Diseases)
Harvard Medical School
Boston, Massachusetts
Needs Statement
The USPSTF recommends screening for hepatitis C virus (HCV) infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965.Target Audience
Health care providers screening for HCVObjectives
Upon completion of this education activity, participants will be able to:- Review basics of transmission of hepatitis C
- Identify key groups for screening
Accreditation
CMEThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC). The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
ACGME Competencies
- Patient care
- Medical knowledge
UK Healthcare CECentral certifies this activity for 0.75 hours of participation. CPHCE
University of Kentucky College of Public Health certifies that this educational activity was designated for 1.00 hour of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health. ()
Faculty Disclosure
No speaker or planners have any relevant financial relationships to disclose.The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, the presentation might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Acknowledgement
This activity is jointly provided by the University of Kentucky and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC). In collaboration with Kentucky Aids Education Training Center (KY AETC).CE Content Concerns
Policy
Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504Procedures
- The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
- If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
- Issues regarding activity content also will be reviewed and addressed by the Activity Director.
- A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
- Grievances will be considered when planning future activities.
Appeal Procedure
- Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
- The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
- The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.